Dermazone Holdings

Dermazone Holdings distributes and develops science-backed cosmeceutical, nutraceutical, and pharmaceutical products. The company offers advanced aesthetic solutions, including chemical peels, injectables, and biorevitalization, and healthcare items. It provides effective formulations to professional clinics, pharmacies, and consumers for anti-aging, acne, hyperpigmentation, and hair loss.

The company boasts over two decades of experience, establishing a significant presence in the healthcare and beauty sectors. While precise founding details for the holding structure are not publicly outlined, its sustained development and market expansion are driven by CEO Dr. Emad Ghanem, overseeing its regional footprint.

Dermazone Holdings serves medical professionals, pharmacies, and direct consumers seeking wellness and aesthetic improvements. Its mission is to empower individuals through science-driven innovations that enhance quality of life and well-being, complementing medical procedures. The company aims to be a premier provider, expanding its portfolio to meet evolving demands.